Evidence map›Paper›PMID 32695922›Full record

ArticleContemporary clinical trials communications2020

Effects of taurocholic acid metabolism by gut bacteria: A controlled feeding trial in adult African American subjects at elevated risk for colorectal cancer.

Patricia G Wolf, H Rex Gaskins, Jason M Ridlon, Sally Freels, Alyshia Hamm, Sarah Goldberg, Phyllis Petrilli, Teresa Schering, Sevasti Vergis, Sandra Gomez-Perez and 4 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Patricia G WolfInstitute for Health Research and Policy, University of Illinois, IL, 60608, USA.
H Rex GaskinsCarl R. Woese Institute for Genomic Biology, Urbana, IL, USA.
Jason M RidlonCarl R. Woese Institute for Genomic Biology, Urbana, IL, USA.
Sally FreelsSchool of Public Health, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Alyshia HammUniversity of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.
Sarah GoldbergDivision of Digestive Diseases, Hepatology and Nutrition, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA.
Phyllis PetrilliInstitute for Health Research and Policy, University of Illinois, IL, 60608, USA.
Teresa ScheringUniversity of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.
Sevasti VergisUniversity of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.
Sandra Gomez-PerezDepartment of Clinical Nutrition, Rush University Medical Center, Chicago, IL, 60612, USA.
Cemal YaziciDivision of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Carol BraunschweigDepartment of Kinesiology and Nutrition, University of Illinois at Chicago at Chicago, Chicago, IL, USA.
Ece MutluDivision of Digestive Diseases, Hepatology and Nutrition, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA.
Lisa Tussing-HumphreysInstitute for Health Research and Policy, University of Illinois, IL, 60608, USA.
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · USRush University Medical Center · US

Funding

Cancer Health Equity Career Development ProgramT32CA057699 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Marian L. Fitzgibbon · 2018 to 2026
$3.0M
NCI NIH HHS T32 CA057699
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer and second leading cause of cancer death in the United States. Recent evidence has linked a high fat and animal protein diet and microbial metabolism of host bile acids as environmental risk factors for CRC development. We hypothesize that the primary bile salt taurocholic acid (TCA) is a key, diet-controlled metabolite whose use by bacteria yields a carcinogen and tumor-promoter, respectively. The work is motivated by our published data indicating hydrogen sulfide (H

Indexed as

Colon cancer disparitiesColorectal cancerH2SMicrobial sulfur metabolismProspective randomized crossover feeding trial

Identifiers

PMID32695922
PMCPMC7363648
OpenAlexW3040970001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.